A 6-Months Infliximab Or Placebo Study In UA At High Risk Of RA:Clinical,Radiological And Synovial Benefit

Clinical trial NCT01245361 · COMPLETED

Trial details

NCT number: NCT01245361
Sponsor: Patrick Durez
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Undifferentiated Arthritis

Start date: 2007-11-01
Primary completion: 2011-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.